RoosterBio & Secretome Therapeutics Announce Successful Completion of Large Scale Production for Clinical Stage Cell Therapy Candidate

Portfolio company RoosterBio is advancing scalable cell therapy manufacturing with industry-shaping innovation.

RoosterBio’s cGMP-grade cell expansion medium, prcRoosterNourish™-MSC-CC, and its companion bioreactor feed, prcRoosterReplenish™-MSC-CC, were purpose-built for highly productive, efficient, and scalable cell therapy manufacturing in bioreactors.

This fed-batch media system simplifies workflows and reduces production cost, enabling the manufacture of cutting-edge cell therapies such as STM-01, developed in partnership with Secretome Therapeutics.

As cell therapy developers move toward industrial-scale production, RoosterBio’s integrated bioprocess solutions are helping the field translate innovation into real-world clinical impact.